# Advances in Cytokines and Inflammatory Mechanisms in the Pathogenesis of Interstitial Cystitis/Bladder Pain Syndrome

## TL;DR

This paper reviews how inflammation and cytokines contribute to bladder pain syndrome, aiming to improve treatment strategies.

## Contribution

The paper provides a comprehensive review of inflammatory mechanisms and cytokine roles in IC/BPS pathogenesis.

## Key findings

- Inflammation, including uroepithelial damage and mast cell activation, is central to IC/BPS.
- Cytokines act as key mediators in the progression of interstitial cystitis/bladder pain syndrome.
- Understanding these mechanisms may lead to innovative treatment approaches.

## Abstract

Bladder discomfort, urgency, and frequency of urination are the hallmarks of interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic illness. Although the precise etiology remains unclear, numerous clinical investigations have established inflammation as a pivotal factor in its pathogenesis, encompassing uroepithelial damage, mast cell activation, and neuroinflammatory responses. This review delineates the pathological features and classification of IC/BPS, emphasizing the contribution of inflammatory mechanisms and the involvement of cytokines as key mediators in disease progression. The insights presented aim to guide the advancement of innovative treatment approaches.